Learning chapters
Prefer to test your knowledge rather than reading journals? Complete our chapters and mini-quizzes today to enhance your attitude, skills and knowledge in oncology biosimilars.
CHAPTER 1
Protein biology and biologic medications
Discussing the fundamentals of protein synthesis - a process that produces some of the most used biologics and their biosimilars
CHAPTER 2
Biologic and biosimilar manufacture
Covering development and manufacture of a biologic or biosimilar, inherent variability and quality management
CHAPTER 3
Biologic product stability – background theory
Detailing the types of factors affecting stability and degradation of biologics and biosimilars, and the studies used to measure
CHAPTER 4
Interpretation of stability data
Describing factors to consider for interpretation of stability and the associated data
CHAPTER 5
Excipients
Including reasons for use and classification of excipients and how they maintain biologic or biosimilar stability and integrity
CHAPTER 6
Approving a biosimilar
Summarising the regulatory principles underlying biosimilar approval and how this differs from the reference biopharmaceutical and small molecule generics
CHAPTER 7
Immunogenicity
Discussing factors effecting immunogenicity and resultant safety and efficacy of a biopharmaceutical
Chapter 8
Pharmacovigilance
Evaluating why pharmacovigilance is essential to characterise the safety and efficacy of biopharmaceuticals and biosimilars
Chapter 9
Biosimilars in practice
Detailing what to consider when reviewing a biosimilar for inclusion in a formulary and the role of pharmacists in implementing biosimilars into the health service
chapter 10
Patient considerations and communication
Discussing the educational needs of patients about biosimilars and the pharmacists’ role in delivering advice and support to patients taking biosimilars
Other educational activities
Real world evidence: Abstract library
Summaries of the latest published papers, data and real-world evidence
Real word evidence: case studies
Regional case studies reflecting on the adoption of oncology biosimilars
Expert webinars
Watch experts discuss using biosimilars with real-world cases